Company / Interest Expense per Share
Coherus Oncology, Inc. Interest Expense per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.26
FY2019
5-year range
$0.10 / $0.26
FY2015-FY2019
Trend
+59.2%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share has fluctuated over the past 6 years, ranging from $0.10 in FY2016 to $0.31 in FY2014.
Based on SEC 10-K filings.
0.26 in FY2019 with a 5-year CAGR of -3.8%.
Increased from $0.21 to $0.26 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +37.1%
- 5-Year CAGR
- -3.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, interest expense per share increased 59.2% year-over-year.
- Peak interest expense per share was recorded in FY2014.
- Lowest interest expense per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $0.26 | +59.2% |
| FY2018 | $0.16 | -22.4% |
| FY2017 | $0.21 | +108.6% |
| FY2016 | $0.10 | -37.2% |
| FY2015 | $0.16 | -49.1% |
| FY2014 | $0.31 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026